STOX1 and early-onset autosomal dominant Alzheimer disease: Previous studies on STOX1 have primarily focused on its involvement in non‐cancerous conditions such as Alzheimer's disease [20, 21, 22], preeclampsia [23, 24, 25, 26], and trophoblast dysfunction [27, 28].